(RTTNews) - iBio, Inc. (IBIO) Monday reported encouraging data from a non-GLP non-human primate (NHP) pharmacokinetics study of the company's lead drug candidate IBIO-600 for the treatment of obesity.

A vaccine for shingles could protect against dementia according to a new study that took advantage of a quirk in Wales' vaccine rollout scheme. Testing such a theory is challenging, but a team led by ...

The Independent Data Monitoring Committee (IDMC) has recommended to continue study as planned as there ... 12 subjects evaluated these results are encouraging and in line with our expectations.

His older brother, who works in Merchant Navy, supported him financially and paid his BTech fee. Later, he joined offline coaching in 2016 to study for GATE. Kailash attempted GATE for the first time ...